136 related articles for article (PubMed ID: 8383377)
1. Cytomegalovirus studies on blood donors in north-east Scotland and a review of UK data.
Galea G; Urbaniak SJ
Vox Sang; 1993; 64(1):24-30. PubMed ID: 8383377
[TBL] [Abstract][Full Text] [Related]
2. The incidence and consequences of cytomegalovirus transmission via blood transfusion to low birth weight, premature infants in north east Scotland.
Galea G; Urbaniak SJ
Vox Sang; 1992; 62(4):200-7. PubMed ID: 1322610
[TBL] [Abstract][Full Text] [Related]
3. [Prevalence of anti-CMV antibodies in blood donors in the Sfax region (value in blood transfusion)].
Gargouri J; Elleuch H; Karray H; Rekik H; Hammami A
Tunis Med; 2000; 78(8-9):512-7. PubMed ID: 11190729
[TBL] [Abstract][Full Text] [Related]
4. Seroprevalence of cytomegalovirus antibodies among blood donors and Multitransfused recipients--a study from north India.
Das B; Kaur G; Basu S
Transfus Apher Sci; 2014 Jun; 50(3):438-42. PubMed ID: 24675015
[TBL] [Abstract][Full Text] [Related]
5. Transfusion-transmitted cytomegalovirus infections: significance and control.
Tegtmeier GE
Vox Sang; 1986; 51 Suppl 1():22-30. PubMed ID: 3017003
[TBL] [Abstract][Full Text] [Related]
6. [Detection of specific antibodies to cytomegalovirus in the blood donors in Qingdao].
Zhao CQ; Shao JJ
Zhonghua Liu Xing Bing Xue Za Zhi; 1989 Apr; 10(2):78-81. PubMed ID: 2544278
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of cytomegalovirus antibody in Thai-northeastern blood donors.
Urwijitaroon Y; Teawpatanataworn S; Kitjareontarm A
Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():180-2. PubMed ID: 7886568
[TBL] [Abstract][Full Text] [Related]
8. Serological screening for the prevention of transfusion-acquired cytomegalovirus infection.
Musiani M; Zerbini M; Carpi C; Plazzi M; Sermasi G; Belletti D; Sacchi R
J Infect; 1984 Sep; 9(2):148-52. PubMed ID: 6094671
[TBL] [Abstract][Full Text] [Related]
9. [Prevalence of anti-CMV antibodies in blood donors in Ouagadougou (Burkina Faso)].
Ouédraogo AS; Yaméogo JT; Poda GE; Kientega Y; Ouédraogo Traore R
Med Sante Trop; 2012; 22(1):107-9. PubMed ID: 22871792
[TBL] [Abstract][Full Text] [Related]
10. Prevention of transfusion-transmitted cytomegalovirus infection.
Pamphilon DH; Rider JR; Barbara JA; Williamson LM
Transfus Med; 1999 Jun; 9(2):115-23. PubMed ID: 10354380
[TBL] [Abstract][Full Text] [Related]
11. PREVALENCE AND ASSOCIATED CHARACTERISTICS OF CYTOMEGALOVIRUS (CMV) IMMUNOGLOBULIN ANTIBODIES AMONG BLOOD DONORS AT A UNIVERSITY TEACHING HOSPITAL IN NIGERIA.
Bolarinwa RA; Donbraye E; Ademosu AA; Salawu L
East Afr Med J; 2014 Nov; 91(11):385-90. PubMed ID: 26866086
[TBL] [Abstract][Full Text] [Related]
12. Cytomegalovirus (CMV) seroprevalence in Japanese blood donors and high detection frequency of CMV DNA in elderly donors.
Furui Y; Satake M; Hoshi Y; Uchida S; Suzuki K; Tadokoro K
Transfusion; 2013 Oct; 53(10):2190-7. PubMed ID: 23968359
[TBL] [Abstract][Full Text] [Related]
13. Relation of titers of antibodies to CMV in blood donors to the transmission of cytomegalovirus infection.
Beneke JS; Tegtmeier GE; Alter HJ; Luetkemeyer RB; Solomon R; Bayer WL
J Infect Dis; 1984 Dec; 150(6):883-8. PubMed ID: 6094676
[TBL] [Abstract][Full Text] [Related]
14. [Leukocyte depletion and infection by cytomegalovirus].
Mazeron MC
Transfus Clin Biol; 2000 Jun; 7 Suppl 1():31s-35s. PubMed ID: 10919221
[TBL] [Abstract][Full Text] [Related]
15. Seroprevalence and Seroconversion of Cytomegalovirus in a Large Group of Healthy, German Blood Donors: Potential Contribution to Transfusion Transmitted Infections.
Kowalzik F; Hitzler W; Runkel S; Marron M
Clin Lab; 2020 Apr; 66(4):. PubMed ID: 32255281
[TBL] [Abstract][Full Text] [Related]
16. Window period donations during primary cytomegalovirus infection and risk of transfusion-transmitted infections.
Ziemann M; Heuft HG; Frank K; Kraas S; Görg S; Hennig H
Transfusion; 2013 May; 53(5):1088-94. PubMed ID: 23320406
[TBL] [Abstract][Full Text] [Related]
17. Recognition of cytomegalovirus clinical isolate antigens by sera from cytomegalovirus-negative blood donors.
Rahbar AR; Sundqvist VA; Wirgart BZ; Grillner L; Söderberg-Naucler C
Transfusion; 2004 Jul; 44(7):1059-66. PubMed ID: 15225248
[TBL] [Abstract][Full Text] [Related]
18. Effect of demographic variables on cytomegalovirus antibody seropositivity among prospective blood donors in Jos, Nigeria.
Alao OO; Mamman A; Araoye MO; Joseph E
Niger Postgrad Med J; 2009 Jun; 16(2):139-42. PubMed ID: 19606194
[TBL] [Abstract][Full Text] [Related]
19. The risk of transfusion-acquired CMV infection in seronegative solid-organ transplant recipients receiving non-WBC-reduced blood components not screened for CMV antibody (1984 to 1996): experience at a single Canadian center.
Preiksaitis JK; Sandhu J; Strautman M
Transfusion; 2002 Apr; 42(4):396-402. PubMed ID: 12076284
[TBL] [Abstract][Full Text] [Related]
20. Indications for the use of cytomegalovirus-seronegative blood products.
Preiksaitis JK
Transfus Med Rev; 1991 Jan; 5(1):1-17. PubMed ID: 1666324
[No Abstract] [Full Text] [Related]
[Next] [New Search]
